Monte Rosa Therapeutics, Inc.

Direct answer

Monte Rosa Therapeutics, Inc. is publicly traded on NASDAQ under the ticker GLUE.

Monte Rosa Therapeutics, Inc. is a biopharmaceutical company dedicated to pioneering novel, small-molecule precision medicines. Their core approach involves leveraging the body's inherent mechanisms to precisely eliminate therapeutically relevant proteins. Among their key initiatives is an oral molecular glue degrader designed to target GSPT1, a specific translational termination factor and degron-containing...

Can you invest in Monte Rosa Therapeutics, Inc.?

Yes. Monte Rosa Therapeutics, Inc. trades publicly on NASDAQ as GLUE.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Monte Rosa Therapeutics, Inc.

Detailed equity research is provided by MarketSnap.